chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 04-NOV-2013 the patient was vaccinated with ZOSTAVAX in the arm in a different pharmacy. On an unknown date in November 2013 the patient experienced rash on her arm at the injections site and came to the reporter's pharmacy to seek medical attention. The outcome of event was reported as not resolved. This is report 1 of 2 from same reporter. Additional information has been requested.
Initial report received from a consumer, who is also the patient's parent, on 29 November 2012 with additional information received on 05 December 2012. The event was reported during the course of a vaccine brand usage survey being conducted by a national sampling organization on behalf of Sanofi Pasteur. A two-month-old female patient had received the following vaccinations on 07 August 2012: PENTACEL, PREVNAR 13 and ROTARIX (lot number, route and sites not reported). In August 2012, the patient stopped having regular bowel movements. No additional information was provided. Outcome was not reported. Follow-up information received from a healthcare professional on 26 December 2012. The patient had received dose of PENTACEL (Lot number: C3973AA) intramuscular in left thigh, PREVNAR 13 (manufactured by Wyeth, Lot number: F45135) intramuscular in right thigh and ROTARIX (manufactured by GSK, Lot number: A41F6245A) orally. The patient's had no illness at the time of vaccination. The patient had not received any other vaccine within the 4 weeks of vaccination. The patient has two siblings. On 20 December 2012, the patient oucome was recovered.
Patient received vaccine past its 30 day expiry date; Patient received vaccine past its 30 day expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date) and PRODUCT STORAGE ERROR (Patient received vaccine past its 30 day expiry date) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022 at 11:39 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Mar-2022 at 11:39 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received vaccine past its 30 day expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 day expiry date) and PRODUCT STORAGE ERROR (Patient received vaccine past its 30 day expiry date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Pt was admitted to hospital approx 2 weeks after 2nd dose of Moderna with dx of acute metabolic encephalopathy, fiver, cervical stenosis
Pt starting feeling ill after vaccination. Arm became red painful and swollen Friday night into Saturday worsened. Shot given on a Wednesday. Redness traveled to axillary area. Pt works in a hospital and MD gave her antibiotics on Saturday.
No additional AEs/PQCs reported; Incorrect product Storage; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.       On 19-JUL-2021, varicella virus vaccine live (oka/merck)(VARIVAX) lot number T041685, expiration date 10-DEC-2022 suffered a temperature excursion (product storage error) and the patient was vaccinated with one dose of it on 29-JUL-2021 (route of administration was not provided) for prophylaxis. No adverse events were reported.  The temperature excursion was of -11.4 degrees Celsius for 8 hours and 40 minutes. No other previous temperature excursions were detected. The call was due to digital data logger.
Unknown onset of altered mental status. Last time known well was day of vaccination 2/3/2021. Found altered on 2/9/2021. Working diagnosis is encephalopathy: MRI unrevealing. CVA vs other etiology
Site: Swelling at Injection Site-Mild, Additional Details: After giving the vaccination, patient developed immediate reaction at injection site: warmth, swelling at the site. He did bleed a little and after putting on the bandaid, I went to grab an ice pack and I started applying the icepack to the site. Checked on patient every 5 minutes. Even did a follow up call to him an hour later and he told me he was doing okay. No more warmth in the area, some pain but the swelling had gone down substantially. I suggested to continue to monitor, apply icepack
Employee began to feel nauseous 8 minutes after injection. Nausea resolved 28 minutes after injection without treatment.
blurred vision in right eye; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vision in right eye) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included blood pressure medication for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vision in right eye). At the time of the report, VISION BLURRED (blurred vision in right eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
pt recvd vax; pt exp malaise, achiness, rash & swelling at injection site;
0850am pt. states she felt dizzy, and had numbness and tingling. A plastic blanket was placed on the floor for her to lay down. Pt. Legs elevated. The pt. was drinking water before the incident occurred. A few minutes prior to the incident occurring the patient was asked if she was feeling OK and she said that she was. While the pt. was laying down EMTs, several RNs, and the NP  were by the patient, they were by her side within a minute of her reporting dizziness. Initial vital signs: AOX4, 98 SpO2, 96 HR, the BP was not taken while the Pt. was laying down. Pt. denies allergies, medical history, and states that she did not eat this morning, but drank coffee. Pt. negative for LOC and diaphoresis. This was the second dose of Pfizer that this pt. received. For her first dose the pt. stated that she felt sick for the first few days. 858am:  Pt. states symptoms of dizziness are subsiding. At this time she was also provided a Gatorade and a snack. 901am: The pt. sat up on the blanket and her BP was taken, she began drinking the Gatorade at this time. 902am: 136/94 BP 905am: Pt. sat down in a folding chair. She was talkative, alert, and appear dizzy. 909am: Pt. states she is feeling good and denies nausea. 910am: 120/82 BP 912am: 99 SpO2, 75 HR 914am: Pt. was advised to drink liquids and eat 916am: Pt. left site, approved by NP who advised the Pt. she was able to leave.
Upon walking to the 15 minute observation area I felt a burning sensation that came over my entire body like alcohol in my veins.  I felt it in my stomach, head, hands, all over.   I told the workers that I didnt feel well.  They moved me to the bathroom and propped me up over the sink sitting in a chair.  I felt very lightheaded at that point and somewhat responsive but was feeling very bad.  I looked at my iwatch and my heart rate was 198.  I felt lightheaded like I was going to pass out.  They had me move to the floor to prop my feet above my head.  They checked my blood pressure and it was normal.  I had them get my purse with my Xanax.  I took 1.5 tablets of .25mg Xanax.  My heart rate slowly went back to normal around 80BPM after about 15 minutes.  The rest of the day I felt very tired.  I felt normal again at 8pm with bo further side effects.
03/07 was on amoxicillin , has thought it was allergic RX, but by late pm he was covered and had vesicles in various stages and remains that way with most on his trunk and hair.
Weakness of the arms; chills; digestive issues (bloating, discomfort, rectal inflammation),; digestive issues (bloating, discomfort, rectal inflammation),; digestive issues (bloating, discomfort, rectal inflammation),; digestive issues (bloating, discomfort, rectal inflammation); irregular menstruation (spotting); irregular menstruation (spotting); pains and aches; tightness at injection site; stiff neck; pain in back of head; sore throat; burning/tingling in upper back; burning/tingling in upper back; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Jul2021 at 14:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included ocular migraines and known allergies to penicillin and shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received metronidazole (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 31Jul2021, the patient experienced weakness of the arms, chills, lymph nodes, digestive issues (bloating, discomfort, rectal inflammation), irregular menstruation (spotting), pains and aches, tightness at injection sight, stiff neck, pain in back of head, sore throat, burning and tingling in upper back and all lasting for over a month and counting. On 23Sep2021, the patient underwent PCR test via nasal swab and the result was negative. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events weakness of the arms, chills, lymph nodes, digestive issues (bloating, discomfort, rectal inflammation), irregular menstruation (spotting), pains and aches, tightness at injection sight, stiff neck, pain in back of head, sore throat, burning and tingling in upper back and all lasting for over a month and counting was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included WARFARIN for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE ERYTHEMA (Redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
1.) Rushed to emergency room by ambulance due to seizure on July 9, 2021  2.) Hospitalized on 10/16/21 due to chest and throat pain and shortness of breath
Patient had heart palpitations; This spontaneous case was reported by a pharmacist and describes the occurrence of PALPITATIONS (Patient had heart palpitations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Patient had heart palpitations). At the time of the report, PALPITATIONS (Patient had heart palpitations) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Patient went to the ER and heart palpitation was resolved. It occurred a year and a half ago.  No treatment medications were reported.   Reporter did not allow further contact
Pt was very anxious before getting the vaccine. Rph went over the questions & per pt's consent administered the vaccine. After 5 min pt complained weakness in arm, legs, headache dizziness. & said felt like stroke like symptoms- 911 was called immediately. pt stated she was starting to feel better. 911 came & paramedics did a check up in ambulance & per pts statement of feeling ok pt went home after being checked by paramedics.
Developed tachycardia and elevation in blood pressure after receiving vaccination. Next day experienced headache. Seen by PCP who advised she not receive the 2nd vaccine.
Rash, NauseaVomiting, pruritus Narrative:  Developed dry heaves, rash and itching 9 min after receiving COVID vaccine (1st dose) during observation; Epipen given in vaccination room; transferred to R by ambulance. In ER she was given Diphenhydramine 25 mg PO and Famotidine 20 mg PO. Observed for 1-1/2 hours and discharged.
Approximately 1 week after the covid booster and flu vaccine, I started to have small itchy bumps which I have not had in the past. These bumps have been found everywhere except my face. They are extremely itchy. I have been told by a dermatologist that it is atopic dermatitis which is my immune system targeting my skin. I do not know if this had anything to do with either injection.
This spontaneous report as received from a healthcare worker refers to an unspecified number of unspecified patients. Concomitant medication and pertinent medical history were not provided. On an unknown date an unspecified number of unspecified patients were vaccinated with unspecified number of doses of ROTATEQ (lot #, dose, route and indication were not provided), which were exposed to temperature excursions outside of the recommended storage range. No adverse effect reported. Additional information has been requested.
5pm 12-29-2020 slight headache, that lasted through Wednesday evening, 12-30-2020.  Thursday, 12-31- 2020, no adverse reaction.  Friday, 1-1-2021 , entire body, including internal organs were trembling.   Saturday, 12-31-2020, extremley dizzy, unable to stand, function. Nauseated, extremely dehydrated, extreme exhaustion. This lasted 24 hours.  Sunday, 1-3-2020, still exhausted, but not to extreme. All other symptoms have subsided.
Fever (99 degrees F), aches, chills, coughing, fatique, malaise starting day after vaccines, sore throat
She felt she had the Covid virus; She felt she had the Covid virus; she still could not breath correctly and still having a hard time breathing; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EN6198) at single dose (age at time of vaccination in 58 years) for COVID-19 immunization in the left arm via unknown route on at 28Apr202 at 15:00. The patient did not have any medical history or concomitant medication. The patient family medical history was none. The patient had taken the first dose of Covid vaccine (Lot Number: EN6201) on 07Apr2021 in the left arm after which she felt like she had the flu for 2 days and her nose was runny, fever, shaky, and sweating and then 2 days later she was fine. The patient reported that she had a very, very bad reactions to the first and second Covid vaccines and felt she had the Covid virus (feeling abnormal). Had felt a little bit better and was able to get liquids in her. Was worried she would get dehydrated. After 4 days of getting second shot the worse symptoms had passed but she still could not breath correctly and still having a hard time breathing and was still feeling tired. She was very, very fatigued and tired all the time. The patient pulmonologist had 2 tests done on her on 23Aug2021. The patient visited the cardiologist on 17Aug2021 and the pulmonologist on the 18Aug2021. Patient visited the physician office for the events. The outcome of the event felt she had the Covid virus was recovering. Outcome for the event she still could not breath correctly and still having a hard time breathing.
Loss of taste; soreness in arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Mar-2021 and was forwarded to Moderna on 27-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (soreness in arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (soreness in arm). At the time of the report, AGEUSIA (Loss of taste) and VACCINATION SITE PAIN (soreness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Swollen lymph node around left collar bone. Persisted for 10 days and continues to persist. Patient has experienced this symptom with other vaccines but with less severity and not for more than a few days. Minimal pain or disruption of activities.
crying consistently for 3 1/2 hrs, stopped for 2 1/2 hrs, restarted for 4 hrs;
Mom called on 10/20/16 at 12:20 pm and reported child had a fever of 104 at 4 am and wanted the child to be seen. Mom report after TYLENOL the fever broke at 3 pm next day to 99.8. No S&S of infection.
suspected vaccination failure; 15 people I have spoken to who said they experienced shingles / all of them say they got it after; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case was one of the 16 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR088476: US-GLAXOSMITHKLINE-US2021AMR088496:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088503:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088504:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088507:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088507:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088497:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088499:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088500:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088501:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088502:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088506:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088495:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088494:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088505:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088531:Original Case : US2021AMR088476
Redness, edema, and local hot and itchy in the left upper arm in deltoid area, no fever or other symptom.
About 48 hours after vaccine my throat started hurting and and eventually congestion and fatigue. I?m on day 4 since symptoms started and congestion is at its worse. Occasional dry cough and lack of appetite. Chills and body aches. Feels like a common cold. No fever. COVID PCR test came back negative.
Information has been received from a physician concerning a 14 year old female with no pertinent medical history who on 31-JUL-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast). Concomitant therapy included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA). The physician reported that on 31-JUL-2008 a patient fainted after she received her first and only dose of GARDASIL vaccine (yeast). The patient woke up after few seconds. Recovered 31-JUL-2008. The patient had not eaten anything prior the vaccination. The patient sought medical attention, she was seen by the physician. There was no product quality complaint. Additional information has been requested.
Mild throat swelling; This is a spontaneous report from a contactable Physician (patient). A 50-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at first single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient shared that after her first dose, she had mild throat swelling. It did get better with antihistamine, she did share that information with her allergist and they decided that the benefits of having the second dose outweigh the risk of the second dose. So today, the patient took the second dose and pretreated with Prednisone, Claritin and Pepcid and she did not have any throat swelling the second time. Outcome of the event was recovered.  The reporter considered the event related to BNT162B2.  Information on the lot/batch number has been requested.
This spontaneous report was received from a physician, regarding a 16 year old male patient. The patient had no pertinent medical history, concomitant therapies and drug reactions or allergies. On 05-JAN-2018, the patient was vaccinated with a second dose of GARDASIL 9 (dose, lot #, expiration date, route of administration and anatomical location were not reported). After vaccination in January 2018, the patient experienced dizziness, numbness and high blood pressure (Blood pressure 164/90 & Pulse 118 (units not provided)). Subsequently, the patient was sent to the emergency room and an electrocardiogram and a chest x ray were performed which were normal. The patient was discharged from the hospital. The outcome of dizziness, numbness and high blood pressure was unknown. The causal relationship between vaccination and the events was not reported.
pt recvd vax 21SEP92 & had sz 30OCT92 & taken to hosp; spent 5 wks in treatment dx sleep apnea; 24NOV92 stopped breathing & husband did CPR; hospitalized; had brain surgery 4DEC92 to remove blood clots; MD do not know cause of this;
The patient's right arm is all bruise- It is purple in color.  He cannot raise his arm beyond his shoulder.
Mom called triage nurse complains of child having diarrhea ever since she received shots wonders if there was another  HIB recall advised mom to take child to a pediatrician covered by her insurance for dehydration. Advised pedialyte (which she is taking)